Literature DB >> 32140489

Modification of the 8th AJCC staging system of pancreatic ductal adenocarcinoma.

Teddy Sutardji Nagaria1, Huamin Wang1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32140489      PMCID： PMC7026792          DOI： 10.21037/hbsn.2019.08.01

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  7 in total

1.  Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

Authors:  Peter J Allen; Deborah Kuk; Carlos Fernandez-Del Castillo; Olca Basturk; Christopher L Wolfgang; John L Cameron; Keith D Lillemoe; Cristina R Ferrone; Vicente Morales-Oyarvide; Jin He; Matthew J Weiss; Ralph H Hruban; Mithat Gönen; David S Klimstra; Mari Mino-Kenudson
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

2.  Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.

Authors:  Marianne Huebner; Michael Kendrick; Kaye M Reid-Lombardo; Florencia Que; Terry Therneau; Rui Qin; John Donohue; David Nagorney; Michael Farnell; Michael Sarr
Journal:  J Gastrointest Surg       Date:  2012-03-16       Impact factor: 3.452

3.  Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

Authors:  Jeannelyn S Estrella; Asif Rashid; Jason B Fleming; Matthew H Katz; Jeffrey E Lee; Robert A Wolf; Gauri R Varadhachary; Peter W T Pisters; Eddie K Abdalla; Jean-Nicolas Vauthey; Hua Wang; Henry F Gomez; Douglas B Evans; James L Abbruzzese; Huamin Wang
Journal:  Cancer       Date:  2011-07-06       Impact factor: 6.860

4.  Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.

Authors:  Si Shi; Jie Hua; Chen Liang; Qingcai Meng; Dingkong Liang; Jin Xu; Quanxing Ni; Xianjun Yu
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

5.  Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  H Vuarnesson; R M Lupinacci; O Semoun; M Svrcek; C Julié; P Balladur; C Penna; J B Bachet; M Resche-Rigon; F Paye
Journal:  Eur J Surg Oncol       Date:  2013-08-12       Impact factor: 4.424

6.  Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant.

Authors:  Burcu Saka; Serdar Balci; Olca Basturk; Pelin Bagci; Lauren M Postlewait; Shishir Maithel; Jessica Knight; Bassel El-Rayes; David Kooby; Juan Sarmiento; Takashi Muraki; Irma Oliva; Sudeshna Bandyopadhyay; Gizem Akkas; Michael Goodman; Michelle D Reid; Alyssa Krasinskas; Rhonda Everett; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2016-01-29       Impact factor: 5.344

7.  Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy.

Authors:  Deyali Chatterjee; Matthew H Katz; Wai Chin Foo; Manonmani Sundar; Hua Wang; Gauri R Varadhachary; Robert A Wolff; Jeffrey E Lee; Anirban Maitra; Jason B Fleming; Asif Rashid; Huamin Wang
Journal:  Am J Surg Pathol       Date:  2017-08       Impact factor: 6.298
  7 in total
  4 in total

Review 1.  Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.

Authors:  Mehran Taherian; Huamin Wang
Journal:  Chin Clin Oncol       Date:  2022-06-16

2.  Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma: Recommendations From the Pancreatobiliary Pathology Society.

Authors:  Huamin Wang; Runjan Chetty; Mojgan Hosseini; Daniela S Allende; Irene Esposito; Yoko Matsuda; Vikram Deshpande; Jiaqi Shi; Deepti Dhall; Kee-Taek Jang; Grace E Kim; Claudio Luchini; Rondell P Graham; Michelle D Reid; Olca Basturk; Ralph H Hruban; Alyssa Krasinskas; David S Klimstra; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2021-12-15       Impact factor: 6.298

3.  A National Assessment of Optimal Oncologic Surgery for Distal Pancreatic Adenocarcinomas.

Authors:  Katherine Hrebinko; Samer Tohme; Richard S Hoehn; Samer AlMasri; Sidrah Khan; Christof Kaltenmeier; Kenneth K Lee; Alessandro Paniccia; Amer Zureikat; Ibrahim Nassour
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.327

4.  Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.

Authors:  Dongguang Wei; Mohamed M Zaid; Matthew H Katz; Laura R Prakash; Michael Kim; Ching-Wei D Tzeng; Jeffrey E Lee; Anshuman Agrawal; Asif Rashid; Hua Wang; Gauri Varadhachary; Robert A Wolff; Eric P Tamm; Priya R Bhosale; Anirban Maitra; Eugene J Koay; Huamin Wang
Journal:  Pancreatology       Date:  2020-11-14       Impact factor: 3.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.